Illumina Inc. (ILMN)

293.20
NASDAQ : Health Technology
Prev Close 298.55
Day Low/High 291.00 / 298.20
52 Wk Low/High 268.62 / 380.76
Avg Volume 1.09M
Exchange NASDAQ
Shares Outstanding 147.00M
Market Cap 43.89B
EPS 5.60
P/E Ratio 52.19
Div & Yield N.A. (N.A)

Latest News

Illumina Expands Genomics Accelerator To Cambridge, UK

Illumina Expands Genomics Accelerator To Cambridge, UK

Illumina, Inc. (NASDAQ: ILMN) today announced the global expansion of Illumina Accelerator to Cambridge, United Kingdom.

Illumina, One of My Short Stock Candidates, Shows Mediocre Growth

Illumina, One of My Short Stock Candidates, Shows Mediocre Growth

ILMN shares were down about 15% in Friday trading after they pre-announced a revenue miss for its second quarter.

Illumina Plunges on Lower Second-Quarter Guidance

Illumina Plunges on Lower Second-Quarter Guidance

Shares of Illumina plunge on Friday after lowering its second-quarter revenue expectations amid a deferred sale of at least one its gene-sequencing machine systems.

Illumina Reports Preliminary Revenue For Second Quarter Of Fiscal Year 2019

Illumina Reports Preliminary Revenue For Second Quarter Of Fiscal Year 2019

Illumina, Inc. (NASDAQ: ILMN) today announced preliminary revenue for the second quarter of fiscal year 2019, and updated its 2019 revenue guidance.

Coming Up Short? Here Are Some Stocks to Consider

Coming Up Short? Here Are Some Stocks to Consider

To effectively generate profits, a trader must pick several companies in a sector and short the whole bunch.

As 'Precision Medicine' Starts to Take Off, Here's Who's Poised to Capitalize

As 'Precision Medicine' Starts to Take Off, Here's Who's Poised to Capitalize

Precision medicine is like a smart bomb that bases treatment on a patient's individual genetics. One company makes the hardware and software to help make it happen.

Illumina Files Patent Infringement Suits Related To BGI In Switzerland, Turkey And The US

Illumina Files Patent Infringement Suits Related To BGI In Switzerland, Turkey And The US

Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed three additional patent infringement suits relating to BGI's sequencing products, including the BGISeq-500, MGISeq-2000, and related chemistry reagents.

Pacific Bio Shares Fall on U.K. Antitrust Concern About Illumina Deal

Pacific Bio Shares Fall on U.K. Antitrust Concern About Illumina Deal

Initial inquiry into deal showed it could remove what might be most significant competitive threat to Illumina.

Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc.

Illumina Wins Infringement Suit Against Ariosa Diagnostics, Inc.

Illumina, Inc. (NASDAQ: ILMN) announced today that the High Court of Justice, Chancery Division, Patents Court in the United Kingdom issued a judgment in its favor in the patent infringement suit filed against Ariosa Diagnostics, Inc.

VeriSeq NIPT Solution V2 (Photo: Business Wire)

VeriSeq NIPT Solution V2 (Photo: Business Wire)

Illumina, Inc. (NASDAQ: ILMN) today announced the launch of VeriSeq ™ NIPT Solution v2, a CE-IVD, next-generation sequencing (NGS)-based approach to noninvasive prenatal testing (NIPT).

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

Illumina Files Patent Infringement Suit Against BGI In Denmark

Illumina Files Patent Infringement Suit Against BGI In Denmark

Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed another patent infringement suit against one of BGI Group's subsidiaries, BGI Europe A/S.

Population Health Study Goes Statewide As University Medical Center Of Southern Nevada Serves As Host Site For Enrollment Of 25,000 More Nevadans

Population Health Study Goes Statewide As University Medical Center Of Southern Nevada Serves As Host Site For Enrollment Of 25,000 More Nevadans

The study could expand to a quarter million people, making Nevada the only state in the U.S. to offer such a program

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

Helix Expands Focus To Population Health Solutions And Appoints Illumina Veteran Marc Stapley As CEO

Helix Expands Focus To Population Health Solutions And Appoints Illumina Veteran Marc Stapley As CEO

SAN CARLOS, Calif., April 25, 2019 /PRNewswire/ -- Helix today announced it is broadening its market focus to include health systems, payers and researchers who are interested in sequencing large population cohorts.

Illumina Reports Financial Results For First Quarter Of Fiscal Year 2019

Illumina Reports Financial Results For First Quarter Of Fiscal Year 2019

Illumina, Inc. (NASDAQ: ILMN) today announced its financial results for the first quarter of fiscal year 2019.

The New #37 Most Shorted Nasdaq 100 Component: Illumina

The New #37 Most Shorted Nasdaq 100 Component: Illumina

The most recent short interest data has been released for the 03/29/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

Illumina To Announce First Quarter 2019 Financial Results On Thursday, April 25, 2019

Illumina To Announce First Quarter 2019 Financial Results On Thursday, April 25, 2019

Illumina, Inc. (NASDAQ:ILMN) today announced that it will issue results for first quarter 2019 following the close of market on Thursday, April 25, 2019.

These Intriguing ETFs Are on the Cutting Edge of Disruptive Technologies

These Intriguing ETFs Are on the Cutting Edge of Disruptive Technologies

Ark Invest has developed a series of specialized exchange-traded funds that own shares in companies involved in 'disruptive innovation.'

Illumina Files Patent Infringement Suit Against BGI In Germany

Illumina Files Patent Infringement Suit Against BGI In Germany

Illumina, Inc. (NASDAQ: ILMN) today announced that it has filed a patent infringement suit against BGI Group's subsidiary, Latvia MGI Tech SIA, in the Düsseldorf Regional Court in Germany.

The Mysteries Hidden Within Ancient DNA May Harness The Answers To Today's Mental Health Epidemic.

The Mysteries Hidden Within Ancient DNA May Harness The Answers To Today's Mental Health Epidemic.

Illumina (NASDAQ:ILMN) and the Lundbeck Foundation GeoGenetics Centre at the University of Copenhagen, Denmark partner to explore the relationship between the evolutionary history of select mental and neurological disorders and infectious pathogens.

Illumina Moves Up In Analyst Rankings, Passing Harris

Illumina Moves Up In Analyst Rankings, Passing Harris

In a study of analyst recommendations at the major brokerages, for the underlying components of the S&P 500, Illumina Inc has taken over the #46 spot from Harris Corp. , according to ETF Channel.

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina To Webcast Upcoming Investor Conference Presentation

Illumina, Inc. (NASDAQ:ILMN) today announced that its executives will be speaking at the following investor conference and invited investors to participate via webcast.

The New #40 Most Shorted Nasdaq 100 Component: Illumina

The New #40 Most Shorted Nasdaq 100 Component: Illumina

The most recent short interest data has been released for the 02/15/2019 settlement date, and we here at Dividend Channel like to sift through this fresh data and order the underlying components of the Nasdaq 100 by "days to cover." There are a number of ways to look at short data, for example the total number of shares short; but one metric that we find particularly useful is the "days to cover" metric because it considers both the total shares short and the average daily volume of shares typically traded. The number of shares short is then compared to the average daily volume, in order to calculate the total number of trading days it would take to close out all of the open short positions if every share traded represented a short position being closed.

5 Attractive Ways to Invest in Oncology

5 Attractive Ways to Invest in Oncology

Experts offer their top stock ideas in oncology detection and treatment.

Hot Cancer Detection Stock Still Has Room to Run

Hot Cancer Detection Stock Still Has Room to Run

Guardant's liquid biopsy lets oncologists see all of the genomic information of a patient's tumor with a simple blood test. The alternative is a tissue biopsy which can be expensive and risky.

Illumina Could Rally to Break Its Downtrend

Illumina Could Rally to Break Its Downtrend

Here's how we would play ILMN stock right now.

Yeti Holdings, Cronos Group, Manitowoc: 'Mad Money' Lightning Round

Yeti Holdings, Cronos Group, Manitowoc: 'Mad Money' Lightning Round

Jim Cramer takes a closer look at Yeti Holdings, Cronos Group, Manitowoc, Crispr Therapeutics, Palo Alto Networks, Etsy and more.

TheStreet Quant Rating: B (Buy)